EMA Authorised: Voranigo (vorasidenib) — Les Laboratoires Servier

View source ↗

Summary

Voranigo (vorasidenib) has been authorised in the EU for the treatment of oligodendroglioma and astrocytoma, with orphan medicine designation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Oligodendroglioma

Drugs mentioned

• VORANIGO (VORASIDENIB)

Snippet

Status: Authorised. Therapeutic area: Oligodendroglioma;Astrocytoma. MAH: Les Laboratoires Servier. Decision date: 27/02/2026. Orphan medicine